$1.71
-0.19[-10.00%]
Last update: 2:54PM Get Real Time Here
iBio Stock (AMEX:IBIO), Analyst Ratings, Price Targets, Predictions
iBio Inc has a consensus price target of $0.09, established from looking at the 3 latest analyst ratings. The last 3 analyst ratings were released from JMP Securities, Cantor Fitzgerald, and JMP Securities on February 16, 2023, October 7, 2022, and November 29, 2021. With an average price target of $0.56 between JMP Securities, Cantor Fitzgerald, and JMP Securities, there's an implied -67.45% downside for iBio Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
JMP Securities
Cantor Fitzgerald
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for iBio
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 02/16/2023 | IBIO | Buy Now | iBio | $1.71 | — | JMP Securities | Roy Buchanan | — | Downgrade | Market Outperform → Market Perform | Get Alert |
| 10/07/2022 | IBIO | Buy Now | iBio | $1.71 | -90.06% | Cantor Fitzgerald | Kristen Kluska | $1250 → $85 | Downgrade | Overweight → Neutral | Get Alert |
| 11/29/2021 | IBIO | Buy Now | iBio | $1.71 | -12.28% | JMP Securities | Roy Buchanan | → $750 | Initiates | → Outperform | Get Alert |
FAQ
What is the target price for iBio (IBIO)?
The latest price target for iBio (AMEX: IBIO) was reported by JMP Securities on February 16, 2023. The analyst firm set a price target for $0.00 expecting IBIO to fall to within 12 months (a possible -100.00% downside). 0 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for iBio (IBIO)?
The latest analyst rating for iBio (AMEX: IBIO) was provided by JMP Securities, and iBio downgraded their market perform rating.
When was the last upgrade for iBio (IBIO)?
There is no last upgrade for iBio.
When was the last downgrade for iBio (IBIO)?
The last downgrade for iBio Inc happened on February 16, 2023 when JMP Securities changed their price target from N/A to N/A for iBio Inc.
When is the next analyst rating going to be posted or updated for iBio (IBIO)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of iBio, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for iBio was filed on February 16, 2023 so you should expect the next rating to be made available sometime around February 16, 2024.
Is the Analyst Rating iBio (IBIO) correct?
While ratings are subjective and will change, the latest iBio (IBIO) rating was a downgraded with a price target of $0.00 to $0.00. The current price iBio (IBIO) is trading at is $1.71, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.